Lutale Janet Joy Kachuchuru, Thordarson Hrafnkell, Abbas Zulfiqarali Gulam, Vetvik Kåre
Institute of Medicine, Division of Haraldsplass Deaconal Hospital, University of Bergen, Bergen, Norway.
BMC Nephrol. 2007 Jan 15;8:2. doi: 10.1186/1471-2369-8-2.
The prevalences and risk factors of microalbuminuria are not full described among black African diabetic patients. This study aimed at determining the prevalence of microalbuminuria among African diabetes patients in Dar es Salaam, Tanzania, and relate to socio-demographic features as well as clinical parameters.
Cross sectional study on 91 Type 1 and 153 Type 2 diabetic patients. Two overnight urine samples per patient were analysed. Albumin concentration was measured by an automated immunoturbidity assay. Average albumin excretion rate (AER) was used and were categorised as normalbuminuria (AER < 20 ug/min), microalbuminuria (AER 20-200 ug/min), and macroalbuminuria (AER > 200 ug/min). Information obtained also included age, diabetes duration, sex, body mass index, blood pressure, serum total cholesterol, high-density and low-density lipoprotein cholesterol, triglycerides, serum creatinine, and glycated hemoglobin A1c.
Overall prevalence of microalbuminuria was 10.7% and macroalbuminuria 4.9%. In Type 1 patients microalbuminuria was 12% and macroalbuminuria 1%. Among Type 2 patients, 9.8% had microalbuminuria, and 7.2% had macroalbuminuria. Type 2 patients with abnormal albumin excretion rate had significantly longer diabetes duration 7.5 (0.2-24 yrs) than those with normal albumin excretion rate 3 (0-25 yrs), p < 0.001. Systolic and diastolic blood pressure among Type 2 patients with abnormal albumin excretion rate were significantly higher than in those with normal albumin excretion rate, (p < 0.001). No significant differences in body mass index, glycaemic control, and cholesterol levels was found among patients with normal compared with those with elevated albumin excretion rate either in Type 1 or Type 2 patients. A stepwise multiple linear regression analysis among Type 2 patients, revealed AER (natural log AER) as the dependent variable to be predicted by [odds ratio (95% confidence interval)] diabetes duration 0.090 (0.049, 0.131), p < 0.0001, systolic blood pressure 0.012 (0.003-0.021), p < 0.010 and serum creatinine 0.021 (0.012, 0.030).
The prevalence of micro and macroalbuminuria is higher among African Type 1 patients with relatively short diabetes duration compared with prevalences among Caucasians. In Type 2 patients, the prevalence is in accordance with findings in Caucasians. The present study detects, however, a much lower prevalence than previously demonstrated in studies from sub-Saharan Africa. Abnormal AER was significantly related to diabetes duration and systolic blood pressure.
在非洲黑人糖尿病患者中,微量白蛋白尿的患病率及危险因素尚未得到充分描述。本研究旨在确定坦桑尼亚达累斯萨拉姆市非洲糖尿病患者中微量白蛋白尿的患病率,并分析其与社会人口学特征及临床参数的关系。
对91例1型糖尿病患者和153例2型糖尿病患者进行横断面研究。每位患者采集两份过夜尿液样本进行分析。采用自动免疫比浊法测定白蛋白浓度。使用平均白蛋白排泄率(AER)进行分类,分为正常白蛋白尿(AER < 20 μg/min)、微量白蛋白尿(AER 20 - 200 μg/min)和大量白蛋白尿(AER > 200 μg/min)。收集的信息还包括年龄、糖尿病病程、性别、体重指数、血压、血清总胆固醇、高密度和低密度脂蛋白胆固醇、甘油三酯、血清肌酐以及糖化血红蛋白A1c。
微量白蛋白尿的总体患病率为10.7%,大量白蛋白尿为4.9%。1型糖尿病患者中微量白蛋白尿患病率为12%,大量白蛋白尿为1%。2型糖尿病患者中,9.8%有微量白蛋白尿,7.2%有大量白蛋白尿。白蛋白排泄率异常的2型糖尿病患者糖尿病病程显著长于白蛋白排泄率正常者[7.5(0.2 - 24年)vs 3(0 - 25年),p < 0.001]。白蛋白排泄率异常的2型糖尿病患者收缩压和舒张压显著高于白蛋白排泄率正常者(p < 0.001)。1型和2型糖尿病患者中,白蛋白排泄率正常者与升高者在体重指数、血糖控制及胆固醇水平方面无显著差异。对2型糖尿病患者进行逐步多元线性回归分析,结果显示以AER(自然对数AER)为因变量,由[比值比(95%置信区间)]糖尿病病程0.090(0.049,0.131),p < 0.0001、收缩压0.012(0.003 - 0.021),p < 0.010和血清肌酐0.021(0.012, 0.030)进行预测。
与白种人相比,非洲1型糖尿病患者中微量和大量白蛋白尿的患病率在糖尿病病程相对较短时更高。在2型糖尿病患者中,患病率与白种人研究结果一致。然而,本研究检测到的患病率远低于撒哈拉以南非洲此前的研究结果。异常AER与糖尿病病程及收缩压显著相关。